NCT02675452 2025-07-09AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid LeukemiaAmgenPhase 1 Terminated141 enrolled 46 charts
NCT02895529 2019-05-06A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyXian-Janssen Pharmaceutical Ltd.Phase 4 Terminated61 enrolled